Alaa Al-Masud | Medicine | Innovative Research Award

Innovative Research Award

Alaa Al-Masud
Princess Nourah Bin Abdulrahman Univeristy

Alaa Al-Masud
Affiliation Princess Nourah Bin Abdulrahman Univeristy
Country Saudi Arabia
Scopus ID 56181242600
Documents 8
Citations 145
h-index 6
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0758-9818

Alaa Al-Masud is a researcher affiliated with Princess Nourah Bin Abdulrahman Univeristy in Saudi Arabia whose scholarly record includes work spanning biomedical and health-related research alongside interdisciplinary studies involving biomaterials, adsorption processes, environmental applications, and molecular science. The available publication record demonstrates participation in collaborative research addressing contemporary scientific questions, with recent work appearing in peer-reviewed journals and including publications indexed through major scholarly research platforms. [1]

Abstract

This academic recognition profile presents the research activities and scholarly contributions associated with Alaa Al-Masud. The available record includes publications addressing subjects such as post-bariatric changes in body composition and inflammation, skeletal metastatic niches, nanomaterial-assisted adsorption, and the use of modified biological materials for removal of organic dyes from water. These studies illustrate an interdisciplinary research orientation connecting medicine and molecular science with materials and environmental applications. [1] [2] [3]

Keywords

Alaa Al-Masud, Innovative Research Award, Medicine, biomedical research, molecular science, biomaterials, chitosan, adsorption, environmental research, metabolic health, inflammation, metastatic niche, interdisciplinary research, Saudi Arabia.

Introduction

Contemporary biomedical research increasingly incorporates interdisciplinary approaches that connect clinical questions with molecular, materials, environmental, and computational methods. Within this context, the publication record associated with Alaa Al-Masud reflects collaborative research across several scientific themes. The identified works include research in metabolic health following sleeve gastrectomy, cancer biology, adsorption science, and the development of modified biomaterials for environmental remediation. [1] [2]

The diversity of these studies is relevant to the evaluation of an innovation-oriented research profile because innovation can arise through the application of established scientific principles to new materials, biological systems, analytical frameworks, or multidisciplinary problems. The documented publications provide evidence of engagement with such research questions while also demonstrating collaboration among researchers from different scientific backgrounds. [3] [4]

Research Profile

The available scholarly metrics identify 8 documents, 145 citations, and an h-index of 6 in the supplied researcher record. These indicators provide quantitative context for the visibility of the research output, although bibliometric indicators are best interpreted alongside publication quality, research relevance, collaboration, methodological contribution, and broader scholarly significance. [1]

  • Research domain: Medicine and interdisciplinary biomedical science.
  • Scopus author identifier: 56181242600.
  • Reported documents: 8.
  • Reported citations: 145.
  • Reported h-index: 6.
  • Research collaborations include biomedical, molecular, materials, and environmental science topics.

Research Contributions

A notable component of the publication record concerns metabolic and inflammatory outcomes associated with sleeve gastrectomy. The 2026 study in Metabolites examines longitudinal changes in body composition, resting metabolic rate, and inflammation and considers their associations with dietary polyunsaturated fatty acid balance. This work addresses clinically relevant questions concerning physiological changes following bariatric surgery and the interaction between nutritional factors and metabolic outcomes. [1]

Publications

  1. Longitudinal Changes in Body Composition, Resting Metabolic Rate, and Inflammation After Sleeve Gastrectomy: Associations with Dietary Polyunsaturated Fatty Acid Balance. Metabolites, 2026.
  2. From Bone Marrow Reserve to Metastatic Niche: How Neutrophil-Lineage Cells Shape Skeletal Colonization. International Journal of Molecular Sciences, 2026.
  3. Advanced biomaterial of crosslinked chitosan-citrate/SnO2 nanoparticles for organic dye removal: insight into physicochemical and adsorption characteristics. Polymer Bulletin, 2025.
  4. Chitosan polymer-loaded chemically treated mango (Mangifera indica L.) peel biomass for the adsorption of safranin O dye using Box-Behnken design. Biomass Conversion and Biorefinery, 2025.
  5. Chitosan/Acid Modified Olive Tree (Olea europaea) Leaves as Sustainable Adsorbent for Organic Dye Removal from Water: Adsorption Modeling and Optimization by Box-Behnken Design. International Journal of Environmental Research, 2025.

Research Impact

The supplied bibliometric record reports 145 citations across 8 documents, with an h-index of 6. These measures indicate that the research output has received scholarly attention within the indexed research literature. Citation counts, however, vary according to database coverage, publication age, field-specific citation practices, and indexing policies; consequently, they should be considered descriptive rather than a standalone assessment of research quality. [1]

Award Suitability

The documented research record provides a reasonable basis for consideration under an Innovative Research Award category within the International Popular Scientist Awards. Relevant characteristics include participation in peer-reviewed research, interdisciplinary collaboration, application of experimental and modelling techniques, and investigation of scientific problems with potential biomedical or environmental relevance. [1] [3]

  • Evidence of peer-reviewed scholarly publication.
  • Research addressing contemporary biomedical and molecular questions.
  • Interdisciplinary collaboration involving medicine, molecular science, materials, and environmental applications.
  • Use of advanced biomaterials and experimental optimization methods in selected studies.
  • Documented citation and h-index indicators supporting scholarly visibility.

Award suitability should ultimately be determined through the applicable nomination, review, and evaluation procedures of the International Popular Scientist Awards, including verification of the researcher’s current scholarly record and supporting documentation.

Conclusion

Alaa Al-Masud’s supplied academic record presents an interdisciplinary body of research with connections to medicine, molecular science, biomaterials, and environmental applications. The documented publications address metabolic and inflammatory changes, cancer-related skeletal colonization, and innovative adsorption materials, while the reported bibliometric indicators provide additional context regarding scholarly visibility. Taken together, these characteristics support consideration of the researcher for an Innovative Research Award, subject to formal assessment and verification by the awarding organization.

References

  1. Elsevier. (n.d.). Scopus author details: Alaa Al-Masud, Author ID 56181242600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56181242600
  2. Hamza, F. N., Zhra, M., Holail, J., Alotab, S., Alshater, S., Al-Masud, A. A., & Mohammad, K. S. (2026). From Bone Marrow Reserve to Metastatic Niche: How Neutrophil-Lineage Cells Shape Skeletal Colonization. International Journal of Molecular Sciences, 27.
    DOI: 10.3390/ijms27135975
  3. Abdulhameed, A. S., Abdullah, S., Al-Masud, A. A., Abualhaija, M., & Algburi, S. (2025). Advanced biomaterial of crosslinked chitosan-citrate/SnO2 nanoparticles for organic dye removal: insight into physicochemical and adsorption characteristics. Polymer Bulletin.
    DOI: 10.1007/s00289-025-05807-2
  4. Abdulhameed, A. S., Abdullah, S., Al-Masud, A. A., Abualhaija, M., & Algburi, S. (2025). Chitosan polymer-loaded chemically treated mango (Mangifera indica L.) peel biomass for the adsorption of safranin O dye using Box-Behnken design. Biomass Conversion and Biorefinery.
    DOI: 10.1007/s13399-025-06669-4
  5. Abdulhameed, A. S., Al Omari, R. H., Al-Masud, A. A., Abualhaija, M., Abdullah, S., & Algburi, S. (2025). Chitosan/Acid Modified Olive Tree (Olea europaea) Leaves as Sustainable Adsorbent for Organic Dye Removal from Water: Adsorption Modeling and Optimization by Box-Behnken Design. International Journal of Environmental Research.
    DOI: 10.1007/s41742-024-00737-9
  6. Mohammad, G., Alzaben, A. S., Alshuweishi, Y., Faludah, S. F., Al-Sharafa, M., Alothman, S., Altalhi, A. S., Aljasser, D. S., ALShamri, D. F., Al Shlwi, S., et al. (2026). Longitudinal Changes in Body Composition, Resting Metabolic Rate, and Inflammation After Sleeve Gastrectomy: Associations with Dietary Polyunsaturated Fatty Acid Balance. Metabolites.
    DOI: 10.3390/metabo16090664

Fanny Lemarié | Medicine | Best Researcher Award

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.

Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Dr. Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Professor First Hospital of Jilin University China

Professor Jiancheng Xu (MD, PhD) is a distinguished clinical microbiologist with over 20 years of experience in laboratory medicine. He currently serves as Professor, Doctoral Supervisor, and Deputy Director of the Department of Laboratory Medicine at the First Hospital of Jilin University, China. A joint-training PhD scholar from the University of Louisville, USA, he has made significant contributions to microbiology, diabetic complications, and laboratory diagnostics. He is also a reviewer for several international journals and an influential figure in multiple national medical associations. Outside the lab, he enjoys running and badminton. 🏃‍♂️🏸

Profile

Orcid

🎓 Education

Professor Xu’s academic path reflects a commitment to excellence. He earned his MD from Norman Bethune University of Medical Sciences (1995–2000), followed by an MS in Laboratory Medicine and a PhD in Internal Medicine from Jilin University (2002–2010). He undertook a joint PhD program at the University of Louisville (2008–2009), enhancing his global research exposure. He further completed a postdoctoral fellowship in Laboratory Medicine at China Medical University (2012–2016), solidifying his scientific and clinical foundation. 🎓🧪

💼 Professional Experience

Professor Xu has advanced steadily through academic and clinical ranks. Beginning as a Research Assistant (2000–2006), he became an Attending Physician (2006–2010), Associate Professor (2010–2014), and finally Professor in 2014 at the First Hospital of Jilin University. He currently serves as the Deputy Director of the Department of Laboratory Medicine, mentoring numerous doctoral candidates and leading transformative research. 🧑‍🏫🏥

🔬 Research Interests

Professor Xu’s research spans across vital domains:

  1. 🧠 Mechanism of Diabetic Complications

  2. 🦠 Bacterial Resistance Mechanisms and Surveillance

  3. 📊 Establishment of Reference Intervals for Clinical Tests

  4. 🤖 Disease Prediction Modeling with Machine Learning

  5. 🧬 Trace Element Metabolism in Diabetic Models

His work integrates clinical insights with computational analytics to develop predictive tools and diagnostic advancements in laboratory medicine.

🏆 Awards & Honors

Professor Xu’s outstanding contributions have earned him numerous accolades and appointments:

  • 🏅 Chairman, Society of Laboratory Medicine, Jilin Medical Security Association

  • 🏅 Vice Chairman, Youth Committee, Chinese Society of Laboratory Medicine

  • 🏅 Vice Chairman, Youth Committee, Jilin Medical Association

  • 🏅 Member, Standing Committees across multiple national and provincial laboratory medicine societies

  • 📚 Editorial Board Member, Chinese Journal of Laboratory Medicine

  • 🧪 Reviewer for Biological Trace Element Research, OMICS, and others

He has successfully led over 33 funded research projects, totaling ¥7.04 million RMB.

📚 Publications Top Notes: 

Professor Xu has authored over 125 peer-reviewed articles, with an H-index of 16 and over 1269 citations. His top publications as a corresponding author include:

🧬 A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings
Virologica Sinica, 2020 – Cited by 39 articles

🧫 The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases
Journal of Immunology Research, 2020 – Cited by 27 articles

🧪 Negative Results in Nucleic Acid Test of COVID-19 Patients: Assessment from Clinical Laboratories
Annals of Palliative Medicine, 2020 – Cited by 18 articles

⚖️ Age- and Sex-Specific Pediatric Reference Intervals of Serum Electrolytes
American Journal of Clinical Pathology, 2020 – Cited by 21 articles

🧫 Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2
Health Security, 2020 – Cited by 14 articles

❤️ Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in COVID-19
BioMed Research International, 2020 – Cited by 33 articles

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation